Akebia Therapeutics | AKBA - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Acadia Pharmaceuticals USD 243.27M 14.49M 2026-03
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alnylam Pharmaceuticals USD 825M 4.3M 2026-03
Amgen USD 6.89B 415M 2025-12
Ardelyx USD 114.37M 8.02M 2025-12
Astellas Pharma JPY 444.26B 12.55B 2026-03
AstraZeneca USD 12.61B 225M 2026-03
Bayer EUR 6.94B 1.58B 2025-12
BioMarin Pharmaceutical USD 571.21M 141.8M 2026-03
Celltrion KRW 46.98B 579.12B 2025-12
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Exelixis USD 590.86M 18.68M 2026-03
Fresenius Medical Care EUR 1.18B 210M 2026-03
GlaxoSmithKline GBP 5.75B 429M 2026-03
Ionis Pharmaceuticals USD 243M 48M 2026-03
Ironwood Pharmaceuticals USD 85.24M 44.1M 2025-06
J&J USD 17.24B 642M 2026-03
Kangmei Pharma CNY 270.29M 20.26M 2025-09
Karyopharm Therapeutics USD 32.6M 63.38M 2025-12
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Lexicon Pharmaceuticals USD 5.29M 8.88M 2025-12
Medical Developments International AUD 7.35M 7.37M 2025-06
Moderna USD -566M 792M 2026-03
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Organigram Holdings CAD 23.32M 8.52M 2025-12
Pharma Mar EUR 39.24M 47.46M 2026-03
Prothena USD 21K 2.39M 2025-12
PTC Therapeutics USD 232.94M 84.56M 2026-03
Qiagen NV USD 325.27M 19.53M 2025-12
Regeneron Pharmaceuticals USD 2.94B 363.7M 2026-03
Roche Holding CHF 22.09B 10.04B 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
Sarepta Therapeutics USD 621.34M 577.79M 2026-03
Sartorius EUR 414.5M 18.3M 2026-03
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Tectonic Therapeutic USD 0 0 2025-03
Tilray USD 57.47M 10.16M 2025-06
Vanda Pharmaceuticals USD 50.6M 5.5M 2024-12
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zz Pientze Pharmaceu CNY 1.16B 860.2M 2026-03